187 related articles for article (PubMed ID: 8914042)
1. Blunted cGMP response to agonists and enhanced glomerular cyclic 3',5'-nucleotide phosphodiesterase activities in experimental congestive heart failure.
Supaporn T; Sandberg SM; Borgeson DD; Heublein DM; Luchner A; Wei CM; Dousa TP; Burnett JC
Kidney Int; 1996 Nov; 50(5):1718-25. PubMed ID: 8914042
[TBL] [Abstract][Full Text] [Related]
2. Chronic administration of phosphodiesterase type 5 inhibitor suppresses renal production of endothelin-1 in dogs with congestive heart failure.
Yamamoto T; Wada A; Ohnishi M; Tsutamoto T; Fujii M; Matsumoto T; Takayama T; Wang X; Kurokawa K; Kinoshita M
Clin Sci (Lond); 2002 Aug; 103 Suppl 48():258S-262S. PubMed ID: 12193099
[TBL] [Abstract][Full Text] [Related]
3. Co-operation between particulate and soluble guanylyl cyclase systems in the rat renal glomeruli.
Stepinski J; Wendt U; Lewko B; Angielski S
J Physiol Pharmacol; 2000 Sep; 51(3):497-511. PubMed ID: 11016869
[TBL] [Abstract][Full Text] [Related]
4. Maximizing the renal cyclic 3'-5'-guanosine monophosphate system with type V phosphodiesterase inhibition and exogenous natriuretic peptide: a novel strategy to improve renal function in experimental overt heart failure.
Chen HH; Huntley BK; Schirger JA; Cataliotti A; Burnett JC
J Am Soc Nephrol; 2006 Oct; 17(10):2742-7. PubMed ID: 16928803
[TBL] [Abstract][Full Text] [Related]
5. Phosphodiesterase inhibitors correct resistance to natriuretic peptides in rats with Heymann Nephritis.
Valentin JP; Ying WZ; Sechi LA; Ling KT; Qiu C; Couser WG; Humphreys MH
J Am Soc Nephrol; 1996 Apr; 7(4):582-93. PubMed ID: 8724892
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin-converting enzyme inhibition prevents myocardial infarction-induced increase in renal cortical cGMP and cAMP phosphodiesterase activities.
Clauss F; Charloux A; Piquard F; Doutreleau S; Talha S; Zoll J; Lugnier C; Geny B
Fundam Clin Pharmacol; 2015 Aug; 29(4):352-61. PubMed ID: 25939307
[TBL] [Abstract][Full Text] [Related]
7. Regulation of cGMP by soluble and particulate guanylyl cyclases in cultured human airway smooth muscle.
Hamad AM; Range S; Holland E; Knox AJ
Am J Physiol; 1997 Oct; 273(4):L807-13. PubMed ID: 9357856
[TBL] [Abstract][Full Text] [Related]
8. Vasorelaxing effects of atrial and brain natriuretic peptides on coronary circulation in heart failure.
Matsumoto T; Wada A; Tsutamoto T; Omura T; Yokohama H; Ohnishi M; Nakae I; Takahashi M; Kinoshita M
Am J Physiol; 1999 Jun; 276(6):H1935-42. PubMed ID: 10362673
[TBL] [Abstract][Full Text] [Related]
9. Maturation of A71915-dependent inhibition of atrial natriuretic peptide-stimulated cyclic GMP production in isolated rat glomeruli.
Norling LL; von Geldern T; Chevalier RL
Biol Neonate; 1994; 66(5):294-301. PubMed ID: 7873695
[TBL] [Abstract][Full Text] [Related]
10. Cardiorenal and neurohumoral effects of endogenous atrial natriuretic peptide in dogs with severe congestive heart failure using a specific antagonist for guanylate cyclase-coupled receptors.
Wada A; Tsutamoto T; Matsuda Y; Kinoshita M
Circulation; 1994 May; 89(5):2232-40. PubMed ID: 7910118
[TBL] [Abstract][Full Text] [Related]
11. Localization of cGMP after infusion of ANP or nitroprusside in the maturing rat.
Chevalier RL; Fern RJ; Garmey M; el-Dahr SS; Gomez RA; De Vente J
Am J Physiol; 1992 Mar; 262(3 Pt 2):F417-24. PubMed ID: 1313644
[TBL] [Abstract][Full Text] [Related]
12. Role of cyclic AMP- and cyclic GMP-phosphodiesterases in the control of cyclic nucleotide levels and smooth muscle tone in rat isolated aorta. A study with selective inhibitors.
Schoeffter P; Lugnier C; Demesy-Waeldele F; Stoclet JC
Biochem Pharmacol; 1987 Nov; 36(22):3965-72. PubMed ID: 2825708
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of cyclic GMP phosphodiesterases augments renal responses to atrial natriuretic factor in congestive heart failure.
Margulies KB; Burnett JC
J Card Fail; 1994 Oct; 1(1):71-80. PubMed ID: 9420635
[TBL] [Abstract][Full Text] [Related]
14. Role of cyclic nucleotide phosphodiesterase isozymes in intact canine trachealis.
Torphy TJ; Zhou HL; Burman M; Huang LB
Mol Pharmacol; 1991 Mar; 39(3):376-84. PubMed ID: 1848659
[TBL] [Abstract][Full Text] [Related]
15. Unilateral ureteral obstruction increases glomerular soluble guanylyl cyclase activity.
McDowell KA; Chevalier RL; Thornhill BA; Norling LL
J Am Soc Nephrol; 1995 Nov; 6(5):1498-503. PubMed ID: 8589329
[TBL] [Abstract][Full Text] [Related]
16. Characterization and selective inhibition of cyclic nucleotide phosphodiesterase isozymes in canine tracheal smooth muscle.
Torphy TJ; Cieslinski LB
Mol Pharmacol; 1990 Feb; 37(2):206-14. PubMed ID: 2154670
[TBL] [Abstract][Full Text] [Related]
17. Equimolar doses of atrial and brain natriuretic peptides and urodilatin have differential renal actions in overt experimental heart failure.
Chen HH; Cataliotti A; Schirger JA; Martin FL; Burnett JC
Am J Physiol Regul Integr Comp Physiol; 2005 May; 288(5):R1093-7. PubMed ID: 15627648
[TBL] [Abstract][Full Text] [Related]
18. ANF-mediated renal cGMP generation in congestive heart failure.
Margulies KB; Heublein DM; Perrella MA; Burnett JC
Am J Physiol; 1991 Apr; 260(4 Pt 2):F562-8. PubMed ID: 1849364
[TBL] [Abstract][Full Text] [Related]
19. Abnormal glomerular response to atrial natriuretic peptide in rats with aortocaval fistulas.
Norling LL; Thornhill BA; Chevalier RL
J Am Soc Nephrol; 1996 Jul; 7(7):1038-44. PubMed ID: 8829119
[TBL] [Abstract][Full Text] [Related]
20. Rosiglitazone treatment restores renal responsiveness to atrial natriuretic peptide in rats with congestive heart failure.
Goltsman I; Khoury EE; Aronson D; Nativ O; Feuerstein GZ; Winaver J; Abassi Z
J Cell Mol Med; 2019 Jul; 23(7):4779-4794. PubMed ID: 31087547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
